{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:15:18Z","timestamp":1767665718444},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40615-015-0142-7","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T19:21:45Z","timestamp":1437420105000},"page":"176-182","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality"],"prefix":"10.1007","volume":"3","author":[{"given":"Biree","family":"Andemariam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasia","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"issue":"4 Suppl","key":"142_CR1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512\u201321.","journal-title":"Am J Prev Med"},{"issue":"20","key":"142_CR2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med. 1995;332(20):1317\u201322.","journal-title":"N Engl J Med"},{"issue":"10","key":"142_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033\u201348.","journal-title":"JAMA"},{"issue":"5","key":"142_CR4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1542\/peds.2005-1611","volume":"117","author":"LA Smith","year":"2006","unstructured":"Smith LA, Oyeku SO, Homer C, Zuckerman B. Sickle cell disease: a question of equity and quality. Pediatrics. 2006;117(5):1763\u201370.","journal-title":"Pediatrics"},{"key":"142_CR5","unstructured":"NCI-designated cancer centers [Internet]. Available from: http:\/\/www.cancer.gov\/researchandfunding\/extramural\/cancercenters\/about ."},{"issue":"5","key":"142_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.leukres.2014.02.003","volume":"38","author":"M Delforge","year":"2014","unstructured":"Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, et al. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leuk Res. 2014;38(5):557\u201363.","journal-title":"Leuk Res"},{"issue":"6","key":"142_CR7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1537-2995.2009.02114.x","volume":"49","author":"M Menis","year":"2009","unstructured":"Menis M, Burwen DR, Holness L, Anderson SA. Blood use in the ambulatory setting among elderly in the United States. Transfusion. 2009;49(6):1186\u201394.","journal-title":"Transfusion"},{"issue":"4","key":"142_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000189381","volume":"120","author":"A Christoforidou","year":"2008","unstructured":"Christoforidou A, Pantelidou D, Anastasiadis A, Goutzouvelidis A, Margaritis D, Kotsianidis I, et al. Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy. Acta Haematol. 2008;120(4):195\u20138.","journal-title":"Acta Haematol"},{"issue":"4","key":"142_CR9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pbc.24870","volume":"61","author":"B Andemariam","year":"2014","unstructured":"Andemariam B, Owarish-Gross J, Grady J, Boruchov D, Thrall RS, Hagstrom JN. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care. Pediatr Blood Cancer. 2014;61(4):697\u2013701.","journal-title":"Pediatr Blood Cancer"},{"key":"142_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/TME.0b013e3181da588c","volume":"32","author":"V Odesina","year":"2010","unstructured":"Odesina V, Bellini S, Leger R, Bona R, Delaney C, Andemariam B, et al. Evidence-based sickle cell pain management in the emergency department. Adv Emer Nurs J. 2010;32:102\u201311.","journal-title":"Adv Emer Nurs J"},{"key":"142_CR11","unstructured":"Works T, Jones S, Grady J, Andemariam B. Integrating social worker into adult sickle cell clinic identifies traumatic exposure history as a risk factor for chronic pain. Health and Social Work. In press."},{"issue":"11","key":"142_CR12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0027-9684(15)30727-6","volume":"102","author":"N Artz","year":"2010","unstructured":"Artz N, Whelan C, Feehan S. Caring for the adult with sickle cell disease: results of a multidisciplinary pilot program. J Natl Med Assoc. 2010;102(11):1009\u201316.","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"142_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcmd.2015.01.011","volume":"54","author":"E Belini Junior","year":"2015","unstructured":"Belini Junior E, Silva DG, Torres Lde S, Okumura JV, Lobo CL, Bonini-Domingos CR. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use. Blood Cells Mol Dis. 2015;54(4):321\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"142_CR14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ophtha.2005.05.026","volume":"112","author":"SM Downes","year":"2005","unstructured":"Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112(11):1869\u201375.","journal-title":"Ophthalmology"},{"issue":"4","key":"142_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/bjo.75.4.229","volume":"75","author":"PD Fox","year":"1991","unstructured":"Fox PD, Vessey SJ, Forshaw ML, Serjeant GR. Influence of genotype on the natural history of untreated proliferative sickle retinopathy\u2014an angiographic study. Br J Ophthalmol. 1991;75(4):229\u201331.","journal-title":"Br J Ophthalmol"},{"key":"142_CR16","unstructured":"Elixhauser A, Steiner C. Readmissions to U.S. Hospitals by diagnosis, 2010. Agency for Healthcare and Research Quality; April 2013. Report No.: Statistical Brief #153."},{"issue":"1","key":"142_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1353\/hpu.0.0272","volume":"21","author":"S Lanzkron","year":"2010","unstructured":"Lanzkron S, Haywood Jr C, Fagan PJ, Rand CS. Examining the effectiveness of hydroxyurea in people with sickle cell disease. J Health Care Poor Underserved. 2010;21(1):277\u201386.","journal-title":"J Health Care Poor Underserved"},{"issue":"8","key":"142_CR18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0027-9684(15)31420-6","volume":"100","author":"S Lanzkron","year":"2008","unstructured":"Lanzkron S, Haywood Jr C, Hassell KL, Rand C. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the sickle cell disease adult provider network. J Natl Med Assoc. 2008;100(8):968\u201373.","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"142_CR19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","volume":"148","author":"OW Brawley","year":"2008","unstructured":"Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, et al. National institutes of health consensus development conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932\u20138.","journal-title":"Ann Intern Med"},{"issue":"6","key":"142_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","volume":"85","author":"MH Steinberg","year":"2010","unstructured":"Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol. 2010;85(6):403\u20138.","journal-title":"Am J Hematol"},{"issue":"6","key":"142_CR21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","volume":"29","author":"LP Laurin","year":"2014","unstructured":"Laurin LP, Nachman PH, Desai PC, Ataga KI, Derebail VK. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol Dial Transplant. 2014;29(6):1211\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"142_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pbc.21271","volume":"50","author":"JS Hankins","year":"2008","unstructured":"Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer. 2008;50(2):293\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"142_CR23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","volume":"95","author":"LJ Benjamin","year":"2000","unstructured":"Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood. 2000;95(4):1130\u20136.","journal-title":"Blood"},{"issue":"6","key":"142_CR24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.2004.05123.x","volume":"126","author":"J Wright","year":"2004","unstructured":"Wright J, Bareford D, Wright C, Augustine G, Olley K, Musamadi L, et al. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol. 2004;126(6):878\u201380.","journal-title":"Br J Haematol"},{"issue":"2","key":"142_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/03630269.2015.1023312","volume":"39","author":"SK Ballas","year":"2015","unstructured":"Ballas SK, Vichinsky EP. Is the medical home for adult patients with sickle cell disease a reality or an illusion? Hemoglobin. 2015;39(2):130\u20133.","journal-title":"Hemoglobin"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-015-0142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40615-015-0142-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-015-0142-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T02:59:53Z","timestamp":1717988393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40615-015-0142-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1007\/s40615-015-0142-7","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}